claim: remdesivir-ivermectin combination displays synergistic interaction without improved in vitro antiviral activity against sars-cov-2.
evidence_1: remdesivir-ivermectin combination displays synergistic interaction with improved in vitro", "here, we report on the in vitro synergistic interaction between two fda approved drugs, remdesivir (rdv) and ivermectin (ivm) resulting in enhanced antiviral activity against sars-cov-2, the causative pathogen of covid-19.")